Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Liver Metastasis Colon Cancer
Interventions
DIAGNOSTIC_TEST

Full Gadoxetate-enhanced liver MRI

Standard pulse sequences

DIAGNOSTIC_TEST

Shortened Gadoxetate-enhanced liver MRI

Fewer pulse sequences

Trial Locations (2)

N6A 4V2

RECRUITING

St. Joseph's Healthcare, London

N6A5A5

RECRUITING

London Health Sciences Centre, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT05314400 - Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter